Treatment regimen for administration of phenylacetylglutamine, phenylacetylisoglutamine, and/or phenylacetate
Abstract
The article claimed is a treating tumour disease (a) cancer method, the method comprising a 100mL/provided hour's transfusion rate for pharmaceutical composition the step; the medicine composition comprising 4∶1 the proportion phenylacetyl glutamine and phenylacetyl different glutamine and enriched with a. The further preferred embodiment, the article further claimed is a treating tumour disease (a) cancer method, the method comprising a 100mL/provided hour's transfusion rate for pharmaceutical composition the step; the medicine composition comprising 4∶1 the proportion benzyl acetate (phenylacetyl glutamine or phenylacetyl different glutamine) and enriched with a. The article further claimed is used for the method the medicine composition.
Term
No projected expiry on record.
- Priority
- Filed
- Granted
- Today
44 members in 21 offices
Priority claims2
| Document | Office | Kind | Date |
|---|---|---|---|
| 12156798 | United States of America | A | |
| 9915017 | United States of America | W |
Members44
| Document | Office | Kind | |
|---|---|---|---|
| CA2336945A1 | Canada | A1 | |
| WO0004894A2 | World Intellectual Property Organization (WIPO) | A2 | |
| AU4854299A | Australia | A | |
| WO0004894A3 | World Intellectual Property Organization (WIPO) | A3 | |
| BR9912356A | Brazil | A | |
| ID28160A | Indonesia | A | |
| EP1098643A2 | European Patent Office (EPO) | A2 | |
| US6258849B1 | United States of America | B1 | |
| KR20010071025A | Republic of Korea | A | |
| EA200100168A1 | Eurasian Patent Organization (EAPO) | A1 | |
| CN1319010A | China | A | |
| US2001044466A1 | United States of America | A1 | |
| PL345959A1 | Poland | A1 | |
| HK1037142A1 | Hong Kong, China | A1 | |
| IL140848D0 | Israel | D0 | |
| ZA200100622B | South Africa | B | |
| JP2002521329A | Japan | A | |
| KR20030027087A | Republic of Korea | A | |
| KR20030027088A | Republic of Korea | A | |
| KR20030027089A | Republic of Korea | A | |
| AU759278B2 | Australia | B2 | |
| KR100399658B1 | Republic of Korea | B1 | |
| EP1098643B1 | European Patent Office (EPO) | B1 | |
| KR100414587B1 | Republic of Korea | B1 | |
| AT257378TThis record | Austria | T | |
| ATE257378T1 | Austria | T1 | |
| KR100417100B1 | Republic of Korea | B1 | |
| KR100417101B1 | Republic of Korea | B1 | |
| DE69914084D1 | Germany | D1 | |
| EA004179B1 | Eurasian Patent Organization (EAPO) | B1 | |
| NZ509244A | New Zealand | A | |
| DK1098643T3 | Denmark | T3 | |
| PT1098643E | Portugal | E | |
| ES2214866T3 | Spain | T3 | |
| DE69914084T2 | Germany | T2 | |
| CN1191064C | China | C | |
| CN1605334A | China | A | |
| IL140848A | Israel | A | |
| CN1660061A | China | A | |
| US6943192B2 | United States of America | B2 | |
| CN100400039C | China | C | |
| CA2336945C | Canada | C | |
| JP2011051993A | Japan | A | |
| PL213698B1 | Poland | B1 |
1 legal event, as the office reported them to INPADOC
Events
| Event | Code | |
|---|---|---|
| Publication of translation of european patent specificationUEP | UEP |
Numbers
- Application
- 99932179
Titles2
- German
- PHENYLACETYLGLUTAMIN, PHENYLACETYLISOGLUTAMIN, UND/ODER PHENYLACETAT ZUR BEHANDLUNG VON NEOPLASTISCHEN ERKRANKUNGEN
- English
- PHENYLACETYL GLUTAMINE, PHENYLACETYLISOGLUTAMINE, AND / OR PHENYL ACETATE FOR THE TREATMENT OF NEOPLASTIC DISEASES
Classification
- CPC, 5
- A61K31/198
- A61K31/216
- A61K31/192
- A61K31/195
- A61P35/00
- IPC, 6
- A61K9 08
- A61K31 19
- A61K31 192
- A61K31 195
- A61K31 198
- A61P35 00